Mitochon Pharmaceuticals
Latest round
- Seed
Last raised
- Nov 2014
Total raised
- $0.3M
Investors
- 1
About Mitochon Pharmaceuticals
Mitochon Pharmaceuticals specializes in developing innovative therapeutics targeting mitochondrial dysfunction to tackle serious neurodegenerative and neuromuscular diseases.Founded in 2014, Mitochon Pharmaceuticals, Inc. is based in Blue Bell, US. The company focuses on therapies for mitochondrial dysfunction affecting neurodegenerative conditions.Mitochon Pharmaceuticals specializes in developing therapeutics aimed at mitochondrial dysfunction, specifically for conditions like Amyotrophic Lateral Sclerosis (ALS), Huntington’s Disease (HD), and Alzheimer’s Disease (AD). Their products utilize a platform based on chemical uncouplers or ionophores to enhance energy expenditure and promote cellular survival, addressing issues like calcium overload and oxidative stress.Mitochon Pharmaceuticals generates revenue through strategic partnerships and collaborations with healthcare providers and research institutions. These engagements typically involve licensing agreements aimed at developing and commercializing their mitochondrial-targeting therapies. They are currently developing additional products aimed at neurodegenerative diseases, with specific release dates to be announced. The company is also targeting expansion into broader European markets to reach more healthcare providers and patients.
Who invested in Mitochon Pharmaceuticals
1 investor across 1 round
See all investors in Mitochon Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 5, 2014
Amount
$0.3M
Investors
Questions about Mitochon Pharmaceuticals
Who invested in Mitochon Pharmaceuticals?
Mitochon Pharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mitochon Pharmaceuticals raised?
Mitochon Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mitochon Pharmaceuticals last raise money?
Mitochon Pharmaceuticals's most recent round on record is a Seed, in Nov 2014.
What does Mitochon Pharmaceuticals do?
Mitochon Pharmaceuticals specializes in developing innovative therapeutics targeting mitochondrial dysfunction to tackle serious neurodegenerative and neuromuscular diseases.
Where is Mitochon Pharmaceuticals headquartered?
Mitochon Pharmaceuticals is headquartered in Blue Bell, US.
Which VCs invest in companies like Mitochon Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Mitochon Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Mitochon Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.